Last updated on February 2018

A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer


Brief description of study

This study aims to collect patient reported outcomes and assess treatment satisfaction in active cancer patients treated with rivaroxaban for VTE (venous thromboembolism).

Clinical Study Identifier: NCT02742623

Contact Investigators or Research Sites near you

Start Over

Bayer Clinical Trials Contact

Multiple Locations, Australia
  Connect »